Newsletter Subject

100 Days of Action on the President’s American Patients First Blueprint

From

hhs.gov

Email Address

donotreply@connect.hhs.gov

Sent On

Tue, Aug 21, 2018 03:46 PM

Email Preheader Text

“The President’s blueprint for lower drug prices is working, drug prices are coming down,

[Web Version]( [100 Days of Action on the President’s American Patients First Blueprint]( “The President’s blueprint for lower drug prices is working, drug prices are coming down, and American patients are going to see the savings in their pocketbook.” — Secretary Alex Azar Tomorrow, August 21, marks 100 days since the release of President Trump’s [American Patients First Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs - PDF](. In this short period of time, an unprecedented number of actions have been taken toward structurally rebuilding this entire segment of the economy to lead to enduring lower prices that are sustainable, support innovation, and put American patients first. Below is the introduction to a new report on the 100 days of action from Dan Best, Senior Advisor to the Secretary for Drug Pricing Reform: “For years, American patients have suffered under a drug-pricing system that provides generous incentives for innovation, while too often failing to deliver important medications at an affordable cost. The flaws in America’s drug markets have been a topic of discussion in healthcare policy circles for years, but no comprehensive approach to reform has ever been undertaken. “On May 11, President Trump and Health and Human Services (HHS) Secretary Alex Azar released the American Patients First blueprint, a comprehensive plan to bring down prescription drug prices and out-of-pocket costs. “The extensive number of proposals in the blueprint reflect the scale of the task: restructuring and reforming a fundamentally flawed drug-pricing system that governs a more than $400 billion sector of our economy. Reforms of significant parts of the healthcare market on a similar scale, such as Medicare Part D, have generally taken several years to implement, and several years after that to effect changes across the entire drug market. “In the 100 days since May 11, HHS has taken dozens of actions on the four strategies contemplated in the blueprint: increased competition, better negotiation, incentives for lower list prices, and reducing out-of-pocket costs. Together, these actions have helped bring into focus a vision for a more competitive pharmaceutical marketplace. Pharmaceutical manufacturers, pharmacy benefit managers, and other actors in the market have indicated that they recognize the scale of disruption this would involve. “At the time of the release of the blueprint, few observers believed that, within months, drug manufacturers would begin to change their annual ritual of significant price hikes. Yet that is what happened in the months following. “Within these first 100 days, 15 drug companies have reduced list prices, rolled back planned price increases, or committed to price freezes for the rest of 2018. Cutting list prices and rolling back proposed increases in particular are an unprecedented recognition of the fundamental changes going on in drug markets.” [Drug company responses: 2 lowering prices or rolled back increases, 13 committed to price freezes for rest of 2018, 4 canceled planned price increases] To read the full report, please visit: [ - PDF]( And to read a fact sheet on 100 days of results from the blueprint, please visit: [ - PDF]( ### [Facebook]( [Twitter]( [Instagram]( [YouTube]( This email was sent by: U.S. Department of Health and Human Services 200 Independence Avenue, S.W., Washington, DC, 20201 US [Privacy Policy]( [Update Profile]( [Manage Subscriptions]( [Unsubscribe](

Marketing emails from hhs.gov

View More
Sent On

04/11/2024

Sent On

31/10/2024

Sent On

24/10/2024

Sent On

17/10/2024

Sent On

26/09/2024

Sent On

23/09/2024

Email Content Statistics

Subscribe Now

Subject Line Length

Data shows that subject lines with 6 to 10 words generated 21 percent higher open rate.

Subscribe Now

Average in this category

Subscribe Now

Number of Words

The more words in the content, the more time the user will need to spend reading. Get straight to the point with catchy short phrases and interesting photos and graphics.

Subscribe Now

Average in this category

Subscribe Now

Number of Images

More images or large images might cause the email to load slower. Aim for a balance of words and images.

Subscribe Now

Average in this category

Subscribe Now

Time to Read

Longer reading time requires more attention and patience from users. Aim for short phrases and catchy keywords.

Subscribe Now

Average in this category

Subscribe Now

Predicted open rate

Subscribe Now

Spam Score

Spam score is determined by a large number of checks performed on the content of the email. For the best delivery results, it is advised to lower your spam score as much as possible.

Subscribe Now

Flesch reading score

Flesch reading score measures how complex a text is. The lower the score, the more difficult the text is to read. The Flesch readability score uses the average length of your sentences (measured by the number of words) and the average number of syllables per word in an equation to calculate the reading ease. Text with a very high Flesch reading ease score (about 100) is straightforward and easy to read, with short sentences and no words of more than two syllables. Usually, a reading ease score of 60-70 is considered acceptable/normal for web copy.

Subscribe Now

Technologies

What powers this email? Every email we receive is parsed to determine the sending ESP and any additional email technologies used.

Subscribe Now

Email Size (not include images)

Font Used

No. Font Name
Subscribe Now

Copyright © 2019–2025 SimilarMail.